Economy of New York City

TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results

Retrieved on: 
Monday, August 2, 2021

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ending June 30, 2021 and recent company developments, along with a business outlook for the remainder 2021.

Key Points: 
  • NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ending June 30, 2021 and recent company developments, along with a business outlook for the remainder 2021.
  • Generated $2.3M in total net UKONIQ revenue from launch through the end of Q2 2021, approximately 4 months.
  • The Company will host a conference call today, August 2, 2021, at 8:30 AM ET, to discuss the Companys second quarter ended June 30, 2021 financial results and provide a business outlook for the remainder of 2021.
  • To participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics.

Uxin Files Its Annual Report on Form 20-F

Retrieved on: 
Monday, August 2, 2021

BEIJING, Aug. 01, 2021 (GLOBE NEWSWIRE) -- Uxin Limited (Uxin or the Company) (Nasdaq: UXIN), a leading national online used car dealer in China, today announced it filed its annual report on Form 20-F for the fiscal year ended March 31, 2021 with the Securities and Exchange Commission on July 30, 2021.

Key Points: 
  • BEIJING, Aug. 01, 2021 (GLOBE NEWSWIRE) -- Uxin Limited (Uxin or the Company) (Nasdaq: UXIN), a leading national online used car dealer in China, today announced it filed its annual report on Form 20-F for the fiscal year ended March 31, 2021 with the Securities and Exchange Commission on July 30, 2021.
  • The annual report can be accessed on the Companys investor relations website at http://ir.xin.com as well as the SEC's website at http://www.sec.gov .
  • The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.
  • Uxin Limited (Nasdaq: UXIN) is a leading nationwide online used car dealer in China.

Triterras Files Plan with Nasdaq Related to Delayed Annual Report

Retrieved on: 
Monday, August 2, 2021

SINGAPORE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Triterras Inc. (Nasdaq: TRIT, TRITW) (Triterras or the Company), a leading fintech company focused on trade and trade finance, today announced that on July 31, 2021 it submitted to the Nasdaq Stock Market LLC (Nasdaq) a plan to regain compliance with the Nasdaq Listing Rules.

Key Points: 
  • SINGAPORE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Triterras Inc. (Nasdaq: TRIT, TRITW) (Triterras or the Company), a leading fintech company focused on trade and trade finance, today announced that on July 31, 2021 it submitted to the Nasdaq Stock Market LLC (Nasdaq) a plan to regain compliance with the Nasdaq Listing Rules.
  • If Nasdaq accepts the Companys plan, then Nasdaq may grant the Company an exception of up to 180 calendar days from the due date of the 2021 Annual Report, or until December 27, 2021, to regain compliance.
  • If Nasdaq does not accept the Companys plan, then the Company would have the opportunity to appeal that decision to a Nasdaq hearings panel.
  • Triterras cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

Atlas Technical Consultants Announces Date for Second Quarter 2021 Results

Retrieved on: 
Monday, August 2, 2021

AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (Atlas or the Company), a leading Infrastructure and Environmental solutions provider, announced today that the Company will release its second quarter 2021 financial results after the market closes on Monday, August 16, 2021.

Key Points: 
  • AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (Atlas or the Company), a leading Infrastructure and Environmental solutions provider, announced today that the Company will release its second quarter 2021 financial results after the market closes on Monday, August 16, 2021.
  • A webcast and conference call will be held that same day at 5:00 p.m. Eastern time (4:00 p.m. Central time) to review the Companys second quarter results, discuss recent events and conduct a question-and-answer session.
  • Upon dialing in, please request to join the Atlas Technical Consultants Second Quarter 2021 Earnings Conference Call.
  • Under the name Atlas Technical Consultants, we offer solutions to public and private sector clients in the transportation, commercial, water, government, education, and industrial markets.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Misonix, Inc. Buyout

Retrieved on: 
Friday, July 30, 2021

WILMINGTON, Del., July 30, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A.

Key Points: 
  • WILMINGTON, Del., July 30, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A.
  • announces that it is investigating Misonix, Inc. (Misonix) (NASDAQ GM: MSON ) regarding possible breaches of fiduciary duties and other violations of law related to Misonixs agreement to be acquired by Bioventus Inc. (Bioventus) (NASDAQ GS: BVS ).
  • To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-misonix-inc .
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected] .

Healthwell Acquisition Corp. I Announces Pricing of $250,000,000 Initial Public Offering

Retrieved on: 
Tuesday, August 3, 2021

I (NASDAQ: HWELU ) (Healthwell or the Company) announced the pricing today of its initial public offering (IPO) of 25,000,000 units at a price to the public of $10.00 per unit.

Key Points: 
  • I (NASDAQ: HWELU ) (Healthwell or the Company) announced the pricing today of its initial public offering (IPO) of 25,000,000 units at a price to the public of $10.00 per unit.
  • The units are expected to be listed on The NASDAQ Capital Market (NASDAQ) under the symbol HWELU beginning tomorrow.
  • The offering is expected to close on August 5, 2021, subject to customary closing conditions.
  • This press release contains statements that constitute forward-looking statements, including with respect to the IPO and search for an initial business combination.

IFC, McCormick & Company, and Citi Establish Sustainability-Linked Financing Partnership

Retrieved on: 
Monday, August 2, 2021

Under the initiative, suppliers can qualify for discounted rates on short-term working capital financing when they meet sustainability standards accepted by McCormick.

Key Points: 
  • Under the initiative, suppliers can qualify for discounted rates on short-term working capital financing when they meet sustainability standards accepted by McCormick.
  • At McCormick, were committed to doing whats right for people, communities, and the planet we share.
  • This innovative partnership between McCormick and IFC leverages Citis global Supplier Finance offering.
  • Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions.

Acacia Research to Release Second Quarter 2021 Financial Results

Retrieved on: 
Monday, August 2, 2021

Acacia Research Corporation (Acacia or the Company) (NASDAQ: ACTG) announced today it will release its second quarter 2021 financial results on Monday, August 16, 2021, at 8:00 a.m. ET/ 5:00 a.m. PT.

Key Points: 
  • Acacia Research Corporation (Acacia or the Company) (NASDAQ: ACTG) announced today it will release its second quarter 2021 financial results on Monday, August 16, 2021, at 8:00 a.m. ET/ 5:00 a.m. PT.
  • The Company will host a conference call on the same day to discuss these results at 11:00 a.m. ET/ 8:00 a.m. PT.
  • This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
  • The results achieved in the most recent quarter are not necessarily indicative of the results to be achieved by us in any subsequent quarters, as it is currently anticipated that Acacia Research Corporations financial results will vary, and may vary significantly, from quarter to quarter.

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Retrieved on: 
Friday, July 30, 2021

No conclusions should be drawn about BKTs investment performance from the amount of the Funds distributions or from the terms of the Funds Plan.

Key Points: 
  • No conclusions should be drawn about BKTs investment performance from the amount of the Funds distributions or from the terms of the Funds Plan.
  • The amount distributed per share under a Plan is subject to change at the discretion of the applicable Funds Board.
  • The amendment or termination of a Plan could have an adverse effect on the market price of the Fund's shares.
  • For additional information on BlackRock, please visit www.blackrock.com/corporate | Twitter: @blackrock | LinkedIn: www.linkedin.com/company/blackrock
    BlackRock will update performance and certain other data for the Funds on a monthly basis on its website in the Closed-end Funds section of www.blackrock.com as well as certain other material information as necessary from time to time.

MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Monday, August 2, 2021

The stock options were granted as a material inducement to each new employee accepting employment with MEI in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The stock options were granted as a material inducement to each new employee accepting employment with MEI in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The stock options have a $2.70 exercise price per share, which is equal to the closing price of the Company's common stock on the grant date.
  • The options were granted pursuant to the MEI Pharma, Inc. 2021 Inducement Grant Equity Compensation Plan, and have terms and conditions consistent with the MEI Pharma, Inc.
  • MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer.